1. 68Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer. Issue 5 (23rd June 2021) Authors: Davies, Amy; Foo, Marcus; Gan, Chun Loo; Kourambas, John; Redgrave, Nicholas; Donnellan, Scott; Appu, Sree; Williams, Scott; Coleman, Andrew; Segelov, Eva; Bradley, Jason; Soo, Geoffrey; Ramdave, Shakher; Kwan, Edmond M.; Azad, Arun A. Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 5(2022) Page Start: e204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of advancing age on treatment and outcomes in anal cancer. (July 2014) Authors: Foo, Marcus; Link, Emma; Leong, Trevor; Chu, Julie; Lee, Mark T.; Chander, Sarat; Tran, Phillip K.; Tomaszewski, Jonathan M.; Michael, Michael; Heriot, Alexander; Ngan, Samuel Y. Journal: Acta oncologica Issue: Volume 53:Number 7(2014) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗